Form 4 for COCH Envoy Medical, Inc.
Accepted 2025-06-09 00:00:00 ET · period of report 2024-11-30 · accession 0001062993-25-011296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-09 | 2024-11-30+ | COCH | Lucas Brent T. | CEO, Dir | A - Grant | $1.55 | +12.9K | 216.5K | +6% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-30 | A | A | 5,165 | $1.94 | 208,743 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-05-30 | A | A | 7,742 | $1.29 | 216,485 | D | — | — |